Artisan Partners
FLXN

Artisan Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Artisan Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,255,982
Closed -$26.8M – 361
2021
Q2 		$26.8M Buy
3,255,982
+111,966
+4% +$952K 0.03% 283
2021
Q1 		$28.1M Buy
3,144,016
+67,987
+2% +$779K 0.04% 294
2020
Q4 		$35.5M Buy
3,076,029
+520,308
+20% +$6.05M 0.04% 279
2020
Q3 		$26.6M Buy
2,555,721
+589,572
+30% +$7.22M 0.04% 269
2020
Q2 		$25.9M Buy
1,966,149
+752,282
+62% +$7.8M 0.04% 249
2020
Q1 		$9.55M Buy
1,213,867
+376,863
+45% +$5.68M 0.02% 266
2019
Q4 		$17.3M Buy
+837,004
New +$14.1M 0.03% 267
2018
Q4 		– Sell
-392,022
Closed -$7.33M – 307
2018
Q3 		$7.33M Sell
392,022
-151,766
-28% -$3.49M 0.01% 243
2018
Q2 		$14.1M Buy
+543,788
New +$14.1M 0.03% 225

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners's FLXN Position: Q3 2021 in Review

Artisan Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 3,255,982 shares — an estimated $26.8M sold.

Artisan Partners first reported a position in FLXN in Q2 2018 and held it in 9 quarters. The position peaked at $35.5M in Q4 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • Artisan Partners reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Artisan Partners sold 3,255,982 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $26.8M.
  • Artisan Partners first reported a position in Flexion Therapeutics, Inc. in Q2 2018 and held it in 9 quarters.
  • Artisan Partners's Flexion Therapeutics, Inc. position peaked at $35.5M in Q4 2020.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Artisan Partners's 13F filing for Q3 2021, filed 12 Nov 2021.